Recommendations have been updated for screening and testing for hepatitis B virus (HBV) infection, according to research published in the March 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and ...
Mar 13, 2023
0
15
Approximately 300 million people are chronically infected with the hepatitis B virus (HBV), which can cause liver cirrhosis or cancer. Consequently, there is an urgent need for the development of HBV curative therapies. Due ...
Feb 6, 2023
0
19
Hepatitis B virus (HBV) infections remain a major global health problem—according to the World Health Organization there are around 300 million HBV carriers worldwide. Current treatments rarely succeed in curing the infection.
Jan 10, 2023
0
10
A 300-mg dose of bepirovirsen per week for 24 weeks results in sustained hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA loss in 9–10% of patients with chronic HBV infection, according to a study published ...
Nov 14, 2022
0
27
Around 1.5 million people worldwide become infected with the hepatitis B virus (HBV) every year. A research team led by the Paul-Ehrlich-Institut has identified a previously unknown pathway for the egress of hepatitis B virus ...
Nov 3, 2022
0
14
Hepatitis B virus (HBV) infection is global in nature and induces several liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died ...
Sep 5, 2022
0
15
A new immunological treatment against hepatitis B and D viruses, both of which can cause liver cancer, shows promising results in animal models. Results from the treatment, which is being developed by researchers at Karolinska ...
Aug 26, 2022
0
43
Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...
Jul 28, 2022
0
3
Viral hepatitis is a serious health condition that affects the liver. While hepatitis B and C viruses are commonly targeted by public health measures aiming to reduce the disease burden, there is another, less commonly known ...
Jun 16, 2022
0
8
A new University of Waterloo study shows that current Hepatitis B vaccination, screening, and treatment strategies in Ontario will leave the province well short of its goal to reduce preventable infections that afflict 1,000 ...
Jun 14, 2022
0
14
